RxDoctor Payments Data

Lisa Kessler, DO

Family Medicine · Rainelle, WVNPI 1376837757

Payments from drug & device makers

$163in general payments, 2019–2025

Across 9 payments — averaging $18.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$37
  • Exact Sciences$32
  • Novartis$19
  • Ortho-clinical Diagnostics, Inc.$17
  • Pfizer$16
  • Boehringer Ingelheim$15
  • plus $26 from 2 others

What the payments were for

  • Food & beverage$14891%
  • Education$159%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$163 in reported general payments places this provider in the 35th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$16,054
Medicare patients
99
Services billed
1,141

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide82$93,453
Trelegy ElliptaFluticasone/Umeclidin/Vilanter66$63,813
EliquisApixaban50$54,290
TradjentaLinagliptin45$49,638
JardianceEmpagliflozin15$26,829
TrulicityDulaglutide20$25,190
MounjaroTirzepatide16$23,713
JanuviaSitagliptin Phosphate19$18,355
MyrbetriqMirabegron19$12,511
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$8,470
Humalog Kwikpen U-100Insulin Lispro15$5,061
SynthroidLevothyroxine Sodium47$4,255
ShingrixVaricella-Zoster Ge/As01b/Pf15$2,783
Levothyroxine Sodium233$2,415
Omeprazole178$2,255

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$37$93,45382 claims
Boehringer IngelheimTradjenta, Jardiance$15$76,46860 claims
PfizerEliquis$16$54,29050 claims
Lilly USA, LLCTrulicity, Mounjaro$12$48,90336 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Rainelle

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →